|
+ |
|
→ |
|
+ | UDP |
|
+ |
|
→ |
|
+ | UDP |
* Produces type 1 chain linkage in glycolipids and core-3 O-glycans, but not N-linked glycoproteins.
* May be an important enzyme forming CA19-9 in colon cancer. Beyond serving as a biomarker, CA19-9 also promotes pancreatitis and pancreatic cancer (in mice).
* B3GalT5 efficiently transfers Gal to the GlcNAc of the glycolipid Lc3Cer and to the terminal GalNAc residue of the globoside Gb4.
* It may thus contribute to the formation of CA 19-9, SSEA-3 and elongated core-3 O-glycans.
* Expression is restricted to the colorectum, small intestine, stomach, and pancreas.
ER | Cis- | Medial- | Trans- | TGN |
---|---|---|---|---|
B3GALT5/hsa-miR-660-5p |
---|
miRNA Target | Site Type | Pos. | Context Score | Frac. | Wt. Context | Frac. | Conserved | Quality |
---|---|---|---|---|---|---|---|---|
5'...CAUUGUAUUUUGGA
AAUGGGUA
... 3' GUUGAGGCUAUACG UUACCCA U |
8mer | 11029-11036 | -0.275 | 95.0 | -0.275 | 97.0 | noncon | |
5'...UAUUUUUGUAAGAG
AUGGGUA
C... 3' GUUGAGGCUAUACGU UACCCA U |
7mer-A1 | 11321-11327 | -0.097 | 74.0 | -0.097 | 84.0 | noncon | |
5'...GGGUUUUAGAAGGG
AAUGGGU
G... 3' GUUGAGGCUAUACG UUACCCA U |
7mer-m8 | 4539-4545 | -0.057 | 59.0 | -0.057 | 73.0 | noncon | |
5'...GUCAGUAAGUAGGA
AAUGGGU
G... 3' GUUGAGGCUAUACG UUACCCA U |
7mer-m8 | 4622-4628 | -0.035 | 43.0 | -0.035 | 61.0 | noncon | |
5'...GGUUGCUUAGCAGC
AAUGGGU
U... 3' GUUGAGGCUAUACG UUACCCA U |
7mer-m8 | 6615-6621 | -0.02 | 27.0 | -0.02 | 49.0 | noncon |